i.v. ril-21 (ZymoGenetics inc)
90
Structured Review
ZymoGenetics inc
i.v. ril-21
I.V. Ril 21, supplied by ZymoGenetics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ril-21/ril+21/pmc11024325-0-20-23
Average 90 stars, based on 1 article reviews
I.V. Ril 21, supplied by ZymoGenetics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ril-21/ril+21/pmc11024325-0-20-23
Average 90 stars, based on 1 article reviews
i.v. ril-21 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Therapeutic potential of interleukin-21 in cancer Article Snippet: NCT00389285 , 1/2 , 2006 Completed , Article Title: IFN-gamma-mediated inhibition of human IgE synthesis by IL-21 is associated with a polymorphism in the IL-21R gene. Article Snippet: Stimulation of B cells for proliferative responses or induction of Article Title: Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins. Article Snippet: Purpose Recombinant interleukin-21 (rIL-21) is an immune stimulating cytokine recently tested in two Phase 1 trials for immune responsive cancers.. A secondary objective of these trials was to characterize pharmacodynamic responses to rIL-21 in patients.. Here, we report the eVects of systemic rIL-21 on serum markers of immune stimulation. Article Title: An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma Article Snippet: These were chosen because they are similar to schedules commonly used for Article Title: Therapeutic potential of interleukin-21 in cancer Article Snippet: NCT00347971 , 1 , 2006 Completed , non-Hodgkin’s lymphoma , Safety study of i.v. rIL-21 in combination with Article Title: Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins Article Snippet: Based on the biologic effects demonstrated in preclinical models, Article Title: Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma. Article Snippet: presented at 7th World Melanoma congress; May 2009 •• Phase II study with rIL-21 in chemotherapy naive metastatic or recurrent melanoma patients.. 47.. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. |
